Contract for Clinical Validation Services in respect of the use of Mass Spectrometry for Covid-19 testing
Validation that mass spectrometry can act as a diagnostic screen for patient samples from NHS test centres (i.e. validating P1 to a clinical standard); and validation of workflow to certain specifications (i.e. turnaround time).
Buyer
Department of Health and Social Care (T&T)
Value
£71,020
Published
21 May 2021
Closes
24 Mar 2021
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Direct
Category
Services
Contract starts
25 Mar 2021
Contract ends
16 Apr 2021
CPV classifications
73111000
Research laboratory services
Lots
Lot default Contract for Clinical Validation Services in respect of the use of Mass Spectrometry for Covid-19 testing
£71,020
Validation that mass spectrometry can act as a diagnostic screen for patient samples from NHS test centres (i.e. validating P1 to a clinical standard); and validation of workflow to certain specifications (i.e. turnaround time).
Delivery: United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
21 May 2021
Awarded contract notice on Contracts Finder
Award notice · Web page
DHSC_MASSSPEC_2[contact phone hidden]_HSL_Pathology_signed_Redactedv2
Not provided
DHSC_MASSSPEC_2[contact phone hidden]_HSL_Pathology_signed_Redactedv2
Link
Contains public sector information licensed under the Open Government Licence v3.0.